From clinical chemistry to digital pathology: Read more about how modern medical laboratories and procedures in pathology play a vital role in the detection and prevention of diseases and in medical research.
Monitoring blood test trends alongside unexplained weight loss can provide further clues about a patient’s risk of developing cancer, according to a new study.
A non-invasive urine test detected more than 9 in 10 bladder cancers in a large NHS study – and could reduce urgent cystoscopies significantly.
For many childhood cancers, chemotherapy is the only treatment option. A study explores the trade-off between life-saving treatment at a young age, and delayed side effects unfolding over a lifetime.
Discover the new EIZO PX3150 live at the European Congress of Pathology in Stockholm (September 12–16) at EIZO booth 425. The PX3150 is EIZO's first 30.5-inch, 8-megapixel monitor purpose-built for digital pathology. Learn more...
Discover how integrated workflows, SMART Automation and reliable IHC staining help build confidence from tissue sample to scan. Visit Stand 331 at ECP 2026 to experience pathology differently.
Sakura Finetek has announced the launch of the Sakura Pathology Network, to connect early-career pathologists across Europe to exchange experiences, discuss challenges and learn from one another.
New research offers an explanation for why many men live with prostate cancer for decades while for others it turns lethal: The work identifies which processes cause DNA damage in most of the cancers.
The growing demand for diagnostic testing is pushing laboratories to rethink how they operate – and automation is emerging as the answer. At the Laboratory Equipment and Technology Trade Fair – Labs Expo – held in Poznań, Poland, industry expert Mateusz Kirzyński made the case for a step-by-step approach to robotics and process automation in Life Science laboratories.
A new study shows that phage therapy could help reduce recurrent infections, which happen when the bacteria responsible for UTIs ‘hide’ in the tissue of the bladder.
Findings of a new study suggest that changes in the gut microbiome could be linked to Parkinson’s disease and may eventually help researchers identify new underlying mechanisms for the condition.
Using a specialized “broth”, researchers have developed a way to condense the days-long diagnosis timeline for sepsis to just hours, facilitating faster diagnosis and clinical decision-making.
Type 2 diabetes manifests itself in two fundamentally different ways, depending on a patient's BMI, a new study reveals – with implications for how treatment should be adapted accordingly.
Cancer metastasis is responsible for at least two-thirds of cancer deaths. Researchers have developed a multi-organ chip that mimics how cancer cells spread to distant organs to gain new insights.
New research has identified a previously unknown mechanism of Kabuki syndrome, a rare genetic disorder. The discovery could open new therapeutic perspectives.
Researchers identified a possible biomarker linked to severe suicidal thoughts. It may also help explain why some people recover, opening a new path for research into resilience and prevention.
Blood tests yield vital information about Alzheimer’s disease. However, new research suggests that relevant biomarkers may differ significantly across patient populations.
Digital pathology and spatial omics could enable researchers to see how a tumor's different cell populations function, opening new perspectives for precision cancer therapy.
In a first for the field, a team has grown heart valves on organoids. This work is an important step toward better understanding—and treating—a number of serious heart disorders.
More biomarkers for better insights on Alzheimer's disease: a new study explores how a panel of seven proteins could help predict disease progression and inform more accurate treatment choices.
Invasive fungal infections are notoriously hard to catch early, and even harder to rule out with confidence. At CHU Bordeaux, Dr Frédéric Gabriel has spent years refining how his lab uses β-D-glucan (BDG) testing to sharpen that judgement call – including with the Wako β-glucan test. In this interview, he explains what the guidelines say, what actually happens at the bench, and where he…
Perfectly viable medical devices disappearing from the European market, manufacturers walking away from the EU rather than navigating regulatory demands, patients losing access to products with long, well-documented safety records. The implementation process for the MDR and IVDR has been challenging, to put it mildly – and the journey is far from over. Ahead of the EAAR’s MDR/IVDR Summit…
A new study links metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD) to an elevated risk of cardiovascular disease, cognitive decline, and other metabolic complications.
A common diabetes test could miss the condition in people with sickle cell trait, new research suggests. Understanding this limitation of immunoassay testing could help guide protocols and policies.
In a study, researchers found unusually high levels of urea in the brains of people with frontotemporal dementia and ALS. The findings raise questions about how the brain clears harmful substances.
Researchers have developed a method to enhance the cellular features in pathology slides based on “structural color” – the same effect that gives peacock feathers their unique sheen.
